TPCW
CLX icon

TD Private Client Wealth’s Clorox CLX Stock Holding History

TD Private Client Wealth’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2K Buy
253
+2
+0.8% +$227 ﹤0.01% 965
2025
Q4 		$25.3K Sell
251
-3
-1% -$326 ﹤0.01% 980
2025
Q3 		$31.3K Sell
254
-3
-1% -$372 ﹤0.01% 924
2025
Q2 		$30.9K Sell
257
-11
-4% -$1.47K ﹤0.01% 924
2025
Q1 		$39.5K Sell
268
-36
-12% -$5.5K ﹤0.01% 842
2024
Q4 		$49.4K Sell
304
-21
-6% -$3.44K ﹤0.01% 820
2024
Q3 		$53K Buy
325
+3
+0.9% +$445 ﹤0.01% 820
2024
Q2 		$44K Sell
322
-284
-47% -$39.4K ﹤0.01% 829
2024
Q1 		$92.8K Sell
606
-272
-31% -$40.6K ﹤0.01% 704
2023
Q4 		$125K Sell
878
-93
-10% -$12.4K ﹤0.01% 642
2023
Q3 		$127K Buy
971
+13
+1% +$1.98K 0.01% 605
2023
Q2 		$152K Sell
958
-14,475
-94% -$2.33M 0.01% 597
2023
Q1 		$2.44M Sell
15,433
-7,182
-32% -$1.08M 0.11% 187
2022
Q4 		$3.17M Buy
22,615
+343
+2% +$48.7K 0.15% 144
2022
Q3 		$2.86M Buy
22,272
+2,581
+13% +$372K 0.15% 145
2022
Q2 		$2.78M Buy
19,691
+9,317
+90% +$1.33M 0.14% 160
2022
Q1 		$1.44M Buy
10,374
+9,921
+2,190% +$1.52M 0.06% 280
2021
Q4 		$79K Sell
453
-54
-11% -$9K ﹤0.01% 673
2021
Q3 		$84K Sell
507
-29
-5% -$4.99K ﹤0.01% 653
2021
Q2 		$96.4K Buy
536
+6
+1% +$1.09K ﹤0.01% 623
2021
Q1 		$102K Sell
530
-68
-11% -$13.1K ﹤0.01% 596
2020
Q4 		$121K Buy
598
+56
+10% +$11.6K 0.01% 533
2020
Q3 		$114K Hold
542
– – 0.01% 517
2020
Q2 		$119K Sell
542
-39
-7% -$7.79K 0.01% 505
2020
Q1 		$101K Buy
581
+10
+2% +$1.65K 0.01% 496
2019
Q4 		$87.7K Buy
+571
New +$85.3K 0.01% 537

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TD Private Client Wealth's CLX Position: Q1 2026 in Review

TD Private Client Wealth increased its Clorox (CLX) stake by 0.8% in Q1 2026, buying an estimated $227 and bringing the position to 253 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

TD Private Client Wealth first reported a position in CLX in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.17M in Q4 2022. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • TD Private Client Wealth held 253 shares of Clorox worth $26.2K as of Q1 2026.
  • TD Private Client Wealth bought 2 Clorox shares in Q1 2026, an estimated $227.
  • Clorox made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #965 holding.
  • TD Private Client Wealth first reported a position in Clorox in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Clorox position peaked at $3.17M in Q4 2022.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.